Thomas Andrew Garner
Executive VP & Chief Commercial OfficerMr. Thomas Andrew Garner, also known as Tom, is Executive Vice President and Chief Commercial Officer of ACADIA Pharmaceuticals Inc. from December 9, 2024. Mr. Garner served as Senior Vice President & Chief Commercial Officer of Lexicon Pharmaceuticals, Inc. from October 09, 2023. He joined the Lexicon Pharmaceuticals, Inc. on October 09, 2023. He has pharmaceutical industry experience, having started his career in the United Kingdom with roles of increasing seniority at Boehringer Ingelheim and Eli Lilly before joining Bristol Myers Squibb (BMS) in 2002. During his time at BMS, Mr. Garner held a broad array of roles throughout BMS’ commercial organization including positions at local, country and global levels and across a diverse range of brands and therapeutic areas. In his most recent role, Mr. Garner was the senior vice president and head of the U.S. Cardiovascular and Established Brands business unit. In this role, he had overarching responsibility for several key brands including ELIQUIS® (apixaban), the most prescribed oral, branded medicine in the United States and CAMZYOS® (mavacamten), BMS’ first-in-class treatment for obstructive hypertrophic cardiomyopathy. In addition, he also held responsibility for BMS’ established brands portfolio, which includes medicines such as ABRAXANE® (paclitaxel) and NULOJIX® (belatacept). Prior to this role, Mr. Garner was the global commercial lead for BMS’ lung and head and neck cancer programs, where he led the successful 1L NSCLC global launches of OPDIVO® (nivolumab) and YERVOY® (ipilimumab). Before moving to the United States in 2015, Mr. Garner was the General Manager for BMS Denmark, having spent the first 10 years of his career working in different sales, management and marketing positions across the United Kingdom and Ireland. Mr. Garner holds a BSc (Hons) degree in International Business Management from the Royal Agricultural University (UK) and a certification in General Management from INSEAD (France).
公司职务
- 公司名称Acadia Pharmaceuticals Inc.股票代码ACAD职务Executive VP & Chief Commercial Officer共事同僚
- CECatherine E. Owen AdamsCEO & Director
- SRStephen Richard BiggarIndependent Chairman of the Board
- MCMark C. SchneyerExecutive VP & CFO
- JJJennifer J. RhodesExecutive VP, Chief Legal Officer & Secretary
- SCScott CenciSenior VP, Chief Information & Data Officer
- LALaura A. BregeIndependent Director
- CACarol A. TammingaMember of the Scientific and Clinical Advisory Board
- HYHerbert Y. MeltzerMember of the Scientific and Clinical Advisory Board
